lated in part through signaling pathways that control the ubiquitination state of ENaC lysines. A defect in ubiquitination causes Liddle syndrome, an inherited form of hypertension. Here we determined that ␣-, ␤-, and ␥ENaC are also substrates for lysine acetylation. Trichostatin A (TSA), a histone deacetylase inhibitor, enhanced ENaC acetylation and increased ENaC abundance in the total cell lysate and at the cell surface. Moreover, TSA increased ENaC current in Fischer rat thyroid and kidney collecting duct epithelia. We found that HDAC7 is expressed in the kidney collecting duct, supporting a potential role for this histone deacetylase in ENaC regulation. HDAC7 overexpression reduced ENaC abundance and ENaC current, whereas ENaC abundance and current were increased by silencing of HDAC7. ENaC and HDAC7 form a complex, as detected by coimmunoprecipitation. We observed a reciprocal relationship between acetylation and ubiquitination; TSA reduced ENaC ubiquitination, whereas HDAC7 increased ubiquitination. By reducing ENaC ubiquitination, TSA decreased the rate of ENaC degradation. Thus, acetylation increases epithelial Na ؉ absorption by antagonizing ENaC ubiquitination. This stabilizes ENaC, and hence, increases its abundance at the cell surface.
The epithelial Na ϩ channel (ENaC), 2 a heterotrimer of ␣, ␤, and ␥ subunits, functions as a pathway for Na ϩ transport across epithelial cells (1, 2) . In the kidney collecting duct, ENaC plays an important role in extracellular Na ϩ and volume homeostasis, which is critical for blood pressure regulation (3) . In the lung, ENaC controls the volume and composition of airway surface liquid (4) . Na ϩ absorption is regulated in large part through mechanisms that alter ENaC trafficking. Moreover, defects in ENaC trafficking cause disease. For example, an inherited form of hypertension, Liddle syndrome, is caused by mutations that disrupt PY motifs located in the C termini of ␤-or ␥ENaC (3, 5) . These motifs function as binding sites for the E3 ubiquitin ligase Nedd4-2 (6, 7) . When bound to ENaC, Nedd4-2 catalyzes ubiquitination of lysines within the N termini of all three ENaC subunits (8) . This reduces ENaC expression at the cell surface by increasing ENaC endocytosis and by targeting ENaC to lysosomes for degradation (9, 10) . Conversely, ubiquitin hydrolases deubiquitinate ENaC, increasing surface expression by reducing endocytosis (USP2-45) and enhancing recycling (USP8) (11, 12) . Ubiquitination also functions in the biosynthetic pathway, targeting incorrectly folded and unassembled ENaC subunits for endoplasmic reticulum-associated degradation, although the ubiquitin ligases that mediate this process have not been identified (13, 14) .
ENaC ubiquitination occurs at multiple lysines located within the N termini of ␣-, ␤-, and ␥ENaC (8, 15) . It is clear that these lysines play an important role in ENaC regulation; mutation of all lysines largely recapitulates the effects of PY motif mutations that cause Liddle syndrome (15, 16) . In addition to functioning as a substrate for ubiquitination, lysines can undergo other forms of post-translational modification. For example, lysines can be acetylated, whereby histone acetyltransferases catalyze transfer of an acetyl group from acetylCoA to the target lysine (17) . Conversely, acetyl groups are removed by histone deacetylases (HDACs). As the names of these proteins imply, this process is best characterized in histones, where lysine acetylation/deacetylation regulates transcription by altering chromatin structure. Examples of acetylation of non-histone proteins are also emerging (18) . Acetylation can alter protein function or stability by interfering with alternative lysine modifications (e.g. ubiquitination) or by altering protein interaction sites. For instance, acetylation stabilizes the tumor suppressor p53 by preventing Mdm2-mediated degradation (19) . However, the situation can be more complex. HIF-1␣, which mediates responses to hypoxia, is both stabilized (20) and destabilized (21) depending on which lysines are acetylated. Because lysines play a critical role in ENaC trafficking, we asked whether they might be targets for acetylation, and we investigated a potential role for lysine acetylation in ENaC regulation.
EXPERIMENTAL PROCEDURES
cDNA Constructs-Human ␣-, ␤-, and ␥ENaC in pMT3 were cloned as described previously (22, 23) . ␣-FLAG, ␤-FLAG, and ␥-FLAG contain a FLAG epitope (DYKDDDDK) at the C terminus, and ␣-V5 contains a V5 epitope (GKPIPNPLLGLDST) at the C terminus. The cytoplasmic lysines were mutated to arginine in each subunit (K-R), as described previously (12) . Mouse HDAC7 cDNA was provided by Ronald Evans (24), human HDAC9 cDNA was provided by Victoria Richon (25) , and ubiquitin-HA was provided by Dirk Bohmann (26) . HDAC7 siRNA was obtained from Dharmacon.
Cell Culture and Transfection-HEK 293T cells were cultured in Dulbecco's modified Eagle's medium. Fischer rat thyroid (FRT) cells were cultured on permeable filter supports (Millicell PCF, 0.4-m pore size, 12-mm diameter) in F-12 Coon's medium with 5% fetal calf serum, 100 units/ml penicillin, and 100 g/ml streptomycin at 37°C. Cells were transfected with cDNAs and siRNAs using Lipofectamine 2000 (Invitrogen). Following transfection, 10 M amiloride was added to the culture medium. mpkCCD c14 cells (provided by Alain Vandewalle, Institut National de la Santé et de la Recherche Médicale) were cultured on permeable filter supports in equal volumes of DMEM and Ham's F12 with 60 nM sodium selenate, 5 mg/ml transferrin, 2 mM glutamine, 50 nM dexamethasone, 1 nM triiodothyronine, 10 ng/ml epidermal growth factor, 5 mg/ml insulin, 20 mM D-glucose, 2% FCS, and 20 mM HEPES, pH 7.4, as described previously (27) . The cells were transfected with cDNA or siRNA using HVJ-E following the manufacturer's instructions (GenomONE) in medium lacking antibiotics. Six h after transfection, the cells were cultured in medium containing dexamethasone (50 nM) but not epidermal growth factor or insulin.
Biochemistry-Cells were treated with 700 nM trichostatin A (TSA) or vehicle (ethanol) for 24 h and then lysed in 150 mM NaCl, 50 mM Tris (pH 7.4), 0.5% Nonidet P-40, and protease inhibitor mixture (Sigma). To detect acetylated ENaC, 500 g of protein was immunoprecipitated with anti-acetyl lysine antibody (Cell Signaling Technology) and immobilized protein A (Pierce). After extensive washing, immunoprecipitated proteins were eluted in SDS-PAGE sample loading buffer (100 mM dithiothreitol, 20% glycerol, 100 mM Tris-Cl, pH 6.8, and 4% SDS) at 95°C for 5 min and then separated by SDS-PAGE. Cell lysates (10 g) were also separated by SDS-PAGE. Proteins were detected by immunoblot with anti-FLAG M2 monoclonal antibody-peroxidase conjugate (Sigma) at 1: 5000 dilution and enhanced chemiluminescence (ECL Plus, GE Healthcare).
To detect the cell surface fraction of ENaC, transfected HEK 293T cells were washed with ice-cold PBS-CM (PBS with 1 mM CaCl 2 and MgCl 2 ) three times on ice, labeled with 0.5 mg/ml Sulfo-NHS-biotin (Pierce) in PBS-CM for 20 min on ice, and quenched with 100 mM glycine in PBS-CM for 10 min. After washing three times with PBS-CM, cells were lysed in 0.4% sodium deoxycholate, 1% Nonidet P-40, 63 mM EDTA, 50 mM Tris-HCl, pH 8, and protease inhibitor mixture. Biotin-labeled cell surface proteins were isolated by incubating cell lysate (200 g) with immobilized NeutrAvidin beads (Pierce) for 12 h at 4°C, and then detected by immunoblot (anti-FLAG M2 monoclonal antibody-peroxidase conjugate).
To detect interactions between ␣ENaC and HDAC7, HEK 293T cells were transfected with ␣ENaC-V5, HDAC7-HA, or both (total cDNA kept constant using cDNA encoding GFP). Following cell lysis in 150 mM NaCl, 50 mM Tris (pH 7.4), 0.5% Nonidet P-40, and protease inhibitor mixture (Sigma), we immunoprecipitated ␣ENaC-V5 (1:300 anti-V5 antibody, Sigma) or HDAC7-HA (1:300 anti-HA antibody, Sigma). Following SDS-PAGE, we detected ␣ENaC-V5 and HDAC7-HA by immunoblot.
To detect ubiquitinated ENaC, HEK 293T cells transfected with or without cDNAs encoding ubiquitin-HA, ENaC (␣-FLAG, ␤-FLAG, and ␥-FLAG), and HDAC7 were treated with N-acetyl-leucinyl-leucinyl-norleucinal (ALLN) (10 M) for 12 h. They were lysed in 150 mM NaCl, 50 mM Tris (pH 7.4), 1% Triton X-100, and protease inhibitor mixture (Sigma). 800 g of protein was immunoprecipitated with anti-HA antibody (1:300, Sigma) and immobilized protein A (Pierce), separated by SDS-PAGE, and then detected by immunoblot with anti-FLAG M2 monoclonal antibody-peroxidase conjugate (1:5000, Sigma) and quantitated by densitometry using ImageJ software.
To quantitate the rate of ENaC degradation, HEK 293T cells were treated with cycloheximide (10 g/ml) for 0 -3 h to inhibit protein synthesis, and ␣ENaC was detected and quantitated by immunoblotting, as above. Proteins were detected by immunoblot in mouse kidney collecting duct epithelia (mpkCCD) cells using anti-HDAC7 antibody (Cell Signaling Technology) and anti-␣ENaC antibody (StressMarq Biosciences).
For renal tissue analysis, C57BL/6J mice and Sprague-Dawley rats were obtained from Harlan Laboratories and kept on a standard Harlan Teklad TD.96208 diet until the age of 8 weeks. Animal use and welfare procedures adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals following protocols reviewed and approved by the Medical College of Wisconsin Institutional Animal Care and Use Committee. Mice and rats were anesthetized with isoflurane, and the kidneys were flushed with PBS and then removed. Apical kidney sections corresponding to cortex were isolated (ϳ1 g) and then diced into small pieces with a razor blade. Glomeruli were isolated via differential sieving as described previously (28) . Samples were pulse-sonicated in 10 mM NaCl, 10 mM Tris-HCl, (pH 7.5), 1% Nonidet P-40, and protease inhibitor mixture (Roche Applied Science) for 10 s and centrifuged at 10,000 ϫ g for 10 min. Proteins were separated by SDS-PAGE and detected by immunoblot using HDAC7 antibody (Santa Cruz Biotechnology).
Immunohistochemistry-Sprague-Dawley rat kidneys were fixed in zinc formalin (24 -48 h) and processed for paraffin embedding. Kidney sections were cut at 4 m, dried, and deparaffinized for subsequent labeled streptavidin-biotin immunohistochemistry. The slides were treated with citrate buffer (pH 6) for a total of 35 min. The slides were blocked with a peroxidase block (Dako), avidin block (Vector Laboratories), biotin block (Vector Laboratories), and serum-free protein block (Dako). Tissue sections were incubated for 90 min with anti-HDAC7 antibody (Abcam) and then goat anti-rabbit biotinylated IgG (Biocare Medical) followed by streptavidin horseradish peroxidase (Biocare Medical) and visualized with diaminobenzidine (Dako). To identify collecting ducts, consecutive sections were stained with anti-aquaporin 2 antibody (Santa Cruz Biotechnology). All slides were counterstained with a Mayer hematoxylin (Dako), dehydrated, and mounted with permanent mounting medium (Sakura).
Electrophysiology-Short-circuit current was measured in Ussing chambers using an EC-825 amplifier (Warner Instruments), digitized with a PowerLab interface (ADInstruments), and recorded and analyzed with Chart software (ADInstruments). The apical and basolateral surfaces were bathed in 135 mM NaCl, 1.2 mM CaCl 2 , 1.2 mM MgCl 2 , 2.4 mM K 2 HPO 4 , 0.6 mM KH 2 PO 4 , and 10 mM HEPES (pH 7.4) at 37°C. Amiloride (10 M) was added to the apical solution to quantitate ENaC current.
Statistics-All data are expressed as mean Ϯ S.E. Differences were assessed by paired or unpaired t tests, with significance indicated by p Ͻ 0.05. Immunoblot and immunohistochemistry experiments were carried out three or more times.
RESULTS
ENaC Acetylation-To test whether ENaC subunits are substrates for lysine acetylation, we treated HEK 293 cells for 1 h with the class I and II HDAC inhibitor TSA. In the absence of TSA, we detected minimal acetylated ␣-, ␤-, and ␥ENaC. TSA enhanced acetylation of all three subunits (Fig. 1) . Mutation of all cytoplasmic lysines in ␥ENaC abolished acetylation (Fig. 1) . Thus, ␣-, ␤-, and ␥ENaC are substrates for acetylation. Moreover, each subunit is deacetylated by one or more class I or II HDAC.
Because ENaC functions primarily as a heterotrimer of ␣-, ␤-, and ␥ subunits (22, 29) , we asked whether acetylation would alter ENaC abundance when all three subunits were coexpressed. ␣ENaC migrates as two bands when coexpressed with ␤-and ␥ENaC: an ϳ90-kDa full-length form and a proteolytically cleaved ϳ70-kDa form ( Fig. 2A) (30, 31) . TSA increased the abundance of ␣ENaC both in the total cell lysate and in the biotinylated cell surface fraction (Fig. 2A) . Likewise, TSA increased the abundance of ␤ENaC (which is not proteolytically cleaved) and ␥ENaC (full-length ϳ92-kDa form and cleaved ϳ75-kDa form) in the cell lysate and at the cell surface (Fig. 2B) .
Although ENaC most commonly functions as a heterotrimer, ␣ENaC can generate small amiloride-sensitive currents when expressed alone (23, 32) . When we expressed ␣ENaC without ␤-and ␥ENaC, we detected ␣ENaC protein in the total cell lysate but not at the cell surface (Fig. 2B) . To test whether acetylation might alter ␣ENaC abundance and localization, we treated cells with TSA. In addition to enhancing ␣ENaC abundance in the cell lysate, TSA induced the appearance of ␣ENaC at the cell surface (Fig. 2B) . Thus, acetylation enhances the abundance of ENaC at the cell surface, both when it is assembled as a heterotrimer and when ␣ENaC is expressed alone.
Acetylation Increases ENaC Current-Because acetylation increased ENaC abundance at the cell surface, we predicted that it would increase ENaC current. In FRT epithelia, coexpression of ␣-, ␤-, and ␥ENaC generated transepithelial shortcircuit Na ϩ current that was blocked by the ENaC inhibitor amiloride (Fig. 3A) (33) . Treatment of the cells with TSA (24 h) increased amiloride-sensitive ENaC current (Fig. 3, A and B) . This stimulation was abolished by mutation of all lysines in the ENaC cytoplasmic domains (Fig. 3B) , consistent with a requirement for lysine acetylation.
We also tested the effect of TSA on endogenous ENaC current in mpkCCD (27) . We found that TSA increased amiloridesensitive transepithelial short-circuit current (Fig. 3, C and D) , similar to results in FRT epithelia. Together, the data indicate that lysine acetylation increases ENaC current.
HDAC7 Regulates ENaC-TSA increases acetylation by inhibiting class I and II HDACs. We tested HDAC7 as a candidate to regulate ENaC. HDAC7 protein was present in total kidney lysates from rat and mouse, but comparatively little HDAC7 was detected in glomeruli (Fig. 4A) . By immunohistochemistry in rat kidney, we found that HDAC7 staining was most prominent in the collecting duct; this segment was identified by the presence of aquaporin 2 (Fig. 4B) . Importantly, the collecting duct is a site for ENaC-mediated Na ϩ absorption. To test the effect of HDAC7 on ENaC protein abundance, we coexpressed HDAC7 and ENaC in HEK 293 cells. HDAC7 reduced ␣ENaC (coexpressed with ␤-and ␥ENaC) abundance in the total cell lysate (Fig. 4, C and D) and at the cell surface (Fig. 4C) . In contrast, HDAC9 did not reduce ␣ENaC abundance (Fig. 4, C and D) .
We tested whether HDAC7 would alter ENaC current. In FRT epithelia, HDAC7 decreased amiloride-sensitive shortcircuit current (Fig. 5, A and B) . In mpkCCD epithelia, overexpression of HDAC7 (Fig. 5C ) reduced endogenous ENaC current (Fig. 5D) . Conversely, HDAC7 siRNA reduced expression of endogenous HDAC7 by 78% (Fig. 5E ), which increased ␣ENaC abundance (Fig. 5E ) and ENaC current (Fig. 5F) . A second HDAC7 siRNA produced a similar increase in ENaC current (Fig. 5F ).
We asked whether ENaC and HDAC7 form a complex. When we immunoprecipitated ␣ENaC, we detected coprecipitated HDAC7 in HEK 293 cells that were cotransfected with ENaC and HDAC7, but not in cells transfected with either protein alone (Fig. 6) . Using the reciprocal strategy, we found that ␣ENaC coprecipitated with HDAC7 (Fig. 6 ). These findings indicate that ENaC and HDAC7 interact with one another to form a complex. Together, the data support a role for HDAC7 in ENaC regulation.
Acetylation Antagonizes ENaC Ubiquitination-Because acetylation and ubiquitination both occur on lysine residues, we hypothesized that acetylation might alter ENaC ubiquitination. In HEK 293 cells expressing ␣-, ␤-, and ␥ENaC, we detected ubiquitinated ␣ENaC in the total cell lysate (Fig. 7A,  top panel) . When we increased ENaC acetylation with TSA, ␣ENaC ubiquitination was reduced (Fig. 7A, top panel, and 7B ). We also detected and quantitated the cell surface fraction of ubiquitinated ␣ENaC (labeled with biotin); TSA reduced ubiquitination of cell surface ␣ENaC (Fig. 7A, middle panel, and  7B ). As a reciprocal approach, we overexpressed HDAC7 to reduce acetylation. HDAC7 increased ␣ENaC ubiquitination both in the total cell lysate and in the cell surface fraction (Fig. 7,  C and D) . Thus, we determined that there is an opposing relationship between acetylation and ubiquitination.
Acetylation Reduces ENaC Degradation-Previous work indicates that ubiquitination induces ENaC degradation (8, 15, 34) . We hypothesized that by reducing ubiquitination, acetylation might decrease ENaC degradation. To test this hypothesis, we treated cells with or without TSA, and then quantitated the rate of ␣ENaC (coexpressed with ␤-and ␥ENaC) degradation using a cycloheximide chase assay. In the absence of TSA, ␣ENaC protein disappeared with a half-life of ϳ45 min (Fig. 8,  A and B) . TSA reduced the ENaC degradation rate, increasing the half-life to ϳ150 min. This indicates that acetylation stabilizes ENaC, which explains the increase in ENaC abundance at the cell surface. 
DISCUSSION
In this work, we define a role for lysine acetylation in the regulation of ENaC. We found that acetylation reduced ENaC degradation, enhancing its abundance at the cell surface. As a result, acetylation increased ENaC current in epithelia.
Lysines are substrates for both acetylation and ubiquitination, which had opposing effects on ENaC degradation. Thus, they function as a critical convergence point for ENaC regulation. In contrast to the stabilizing effect we observed for acetylation, ubiquitination reduces ENaC abundance by increasing its degradation (8, 15) . Ubiquitination is a dynamic process; the ubiquitination state is determined by the relative activity of E3 ubiquitin ligases, such as Nedd4-2 (8, 35) , and ubiquitin hydrolases, including USP2-45 (36) and USP8 (12) . Here we showed that the ubiquitination state of ENaC is also modulated by lysine acetylation. Acetylation antagonized ENaC ubiquitination; maneuvers that increased acetylation reduced ubiquitination, whereas deacetylation had the opposite effect. The sim- and HDAC7 or GFP (ϪHDAC7)(0.75 g). Amiloride (10 M) was added to the bathing solution, as indicated by the black bar. B, quantification of amiloride-sensitive short-circuit currents in FRT epithelia (relative to ϪHDAC7 group) (mean Ϯ S.E., n ϭ 11; *, p Ͻ 0.01). C, immunoblot (IB) (anti-FLAG) of HDAC7-FLAG in mpkCCD epithelia transfected with HDAC7-FLAG (ϩ) or GFP (Ϫ)(2.8 g). D, quantification of amiloride-sensitive shortcircuit currents in mpkCCD epithelia transfected with HDAC7 or GFP (relative to ϪHDAC7 group) (mean Ϯ S.E., n ϭ 15-16; *, p Ͻ 0.015). E, immunoblot of endogenous HDAC7 and ␣ENaC in mpkCCD epithelia transfected with HDAC7 siRNA or non-targeting control (Cntrl) siRNA. F, quantification of amiloride-sensitive short-circuit currents in mpkCCD epithelia transfected with two HDAC7 siRNAs or control siRNA (relative to control siRNA group) (mean Ϯ S.E., n ϭ 14 -22; *, p Ͻ 0.009). plest model is one in which ubiquitin ligases and histone acetyltransferases compete for a common set of ENaC lysines. When acetylated, these lysines would no longer be susceptible to ubiquitination. However, there are other potential explanations for the data. Acetylation might reduce ubiquitination indirectly by targeting a different subset of lysines. In this case, acetylation could induce conformational changes that reduce accessibility of ubiquitination sites. Alternatively, acetylation could enhance ENaC deubiquitination by altering accessibility or binding of ubiquitin hydrolases. By opposing ubiquitination, acetylation could regulate ENaC at multiple cellular locations. In the biosynthetic pathway, ubiquitination targets misfolded or incorrectly assembled channels for endoplasmic reticulum-associated degradation (13) . In this location, acetylation could increase ENaC delivery to the cell surface. At the cell surface, ubiquitination functions as a signal to induce ENaC endocytosis (9) . Once it reaches the endosome, ubiquitination mediates sorting between lysosomal degradation and recycling pathways (9, 37) . Thus, acetylation could regulate ENaC in the endocytic pathway, reducing endocytosis and/or increasing recycling. Although additional work will be required to distinguish between these possibilities, our data begin to hint at a role for acetylation in the biosynthetic pathway. First, acetylation stabilized ENaC in the total cell lysate, which predominantly reflects ENaC located in the biosynthetic pathway. Second, when acetylated, we found that ␣ENaC trafficked to the cell surface in the absence of the other two subunits. Without acetylation, efficient forward trafficking requires coassembly of ␣ENaC with ␤-and ␥ENaC; when ␣ENaC is expressed alone, it is ubiquitinated and targeted to the proteasome for degradation (13) (14) (15) . The functional relevance of this observation is unclear. It has been suggested that ␣ENaC homomultimers might be responsible for the high conductance non-selective cation currents observed in alveolar epithelial cells, which contrast with the highly Na ϩ -selective low conductance current produced by ␣␤␥ENaC (38, 39) . Perhaps acetylation underlies the trafficking of these ␣ENaC channels to the cell surface.
The acetylation state of proteins is controlled in part by the activity of HDACs, which deacetylate their targets. Here we defined a role for HDAC7 in the regulation of ENaC surface expression. We found that HDAC7 is expressed in the kidney collecting duct, which is a critical site for ENaC-mediated Na ϩ transport. Moreover, knockdown of HDAC7 increased ENaC current, whereas HDAC7 overexpression had the opposite effect. Previous work indicates that HDAC7 has diverse functional effects. HDAC7 contributes to regulation of bone remodeling, T lymphocyte selection/activity, myocyte migration/ differentiation, and modulation of enzymes involved in intermediate metabolism (40 -43) . HDAC7 is thought to contribute to the pathogenesis of diseases including cystic fibrosis (44) and ␣-1 antitrypsin deficiency (45) . Most of these effects are mediated by its activity as a transcriptional corepressor. In contrast, HDAC7 regulates ENaC through a post-translational mechanism, enhancing ENaC ubiquitination. Although our data support a role for HDAC7, it seems possible that additional HDACs will also contribute to ENaC regulation.
ENaC plays an essential role in controlling extracellular Na ϩ and fluid balance. A defect in ENaC ubiquitination causes an inherited form of hypertension (Liddle syndrome), emphasizing the critical role that ubiquitination plays in the regulation of epithelial Na ϩ transport. In this work, we have identified an additional level of complexity in the signaling pathways that control ENaC ubiquitination. Elucidation of these pathways may provide a deeper understanding of diseases including hypertension, and targeting them may lead to new and more effective treatments.
